Navigation Links
WiSys to distribute $1 million in research funds

Madison, Wis. - The growing body of university research under development beyond the confines of the University of Wisconsin-Madison could grow at an even faster pace as the result of a $1 million allocation approved Friday by University of Wisconsin System presidents and the Wisconsin Alumni Research Foundation.

Full article >>> a patent for their discovery of anti-infective agents derived from Comptonia Peregrina, a native American plant.

UW-Oshkosh has became the first Wisconsin campus and only the 10th nationwide to join the federal Environmental Protection Agency's Renewable Energy Initiative. The Oshkosh campus now leads the state in renewable energy use, having purchased 11......

Full article >>> their breath for a wave of affordable, environment-friendly hydrogen-powered cars just yet. General applications of hydrogen technology are still several years away. "As we move toward an alternative energy economy, it has to be a combination of everything - wind, solar, insulation - to make things work because you won't be able to replace [fossil fuels] with a single solution," Hamilton said.
......

Full article >>> ," John said. "We will continue protecting and patenting, and all the revenue we generate comes back to the campuses for further research and development."

......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner and Joe Vanden Plas 06/19/06


Related biology technology :

1. WiSys to patent Marshfield Clinic discoveries
2. WiSys new manager plans system-wide research awareness
3. Microsoft to distribute $224M as part of settlement
4. WiCell, California firm agree to distribute stem cell lines derived with new technique
5. GE Healthcare to distribute stem cell harvester
6. GenTel to distribute cancer research tool
7. Musicnotes strikes deal to distribute Sony/ATV sheet music
8. Kodak to distribute Cedara mammography medical imaging software
9. EraGen cystic fibrosis test to be distributed worldwide through Bayer
10. Venture Investors early-stage fund grows to $115 million
11. Two convicted of selling $6 million in counterfeit Rockwell software on eBay
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... ... Today, researchers can fast-track sample collection and analysis for ... or SNPs of interest) using one, easy-to-collect saliva sample. With the addition of ... and other relevant biomarkers can be extensively studied through a non-invasive sample type. ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):